Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

• Main Authors: Chee Y. Ooi (Author), Rosie Sutherland (Author), Carlo Castellani (Author), Katherine Keenan (Author), Margaret Boland (Author), Joe Reisman (Author), Candice Bjornson (Author), Mark A. Chilvers (Author), Richard van Wylick (Author), Steven Kent (Author), April Price (Author), Dimas Mateos-Corral (Author), Daniel Hughes (Author), Melinda Solomon (Author), Peter Zuberbuhler (Author), Janna Brusky (Author), Peter R. Durie (Author), Felix Ratjen (Author), Tanja Gonska (Author)
• Format: Book
• Published: BMC, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Newborn screening (NBS) for cystic fibrosis (CF) not only identifies infants with a diagnosis of CF, but also those with an uncertain diagnosis of cystic fibrosis (CF), i.e. CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inco...